Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies

标题
Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 27, Issue 28, Pages 4718-4726
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2009-09-01
DOI
10.1200/jco.2008.21.7125

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More